Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerResumen de Investigación
Analyzed using Evidence Intelligence™
Flash Glucose Monitoring Improves Glycaemic Control in Youth
Última actualización 12 de julio de 2026
Key finding
HbA1c decreased when using FGM versus SMBG (difference -0.44% (4.8 mmol/mol); p=0.006).
This study evaluated the impact of Flash Glucose Monitoring (FGM) on glycaemic control in youth with Type 1 Diabetes in India, finding significant reductions in HbA1c levels compared to self-monitoring.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the impact of Flash Glucose Monitoring (FGM) on glycaemic control in youth with Type 1 Diabetes in India, finding significant reductions in HbA1c levels compared to self-monitoring.
Clinical relevance
Improving glycaemic control is crucial in managing Type 1 Diabetes, as it reduces the risk of long-term complications. This study suggests that FGM could be a more effective tool for monitoring blood glucose in youth, potentially leading to better health outcomes and quality of life for these patients.
Keep in mind
The study's sample size may limit generalizability. Long-term effects beyond 12 months were not assessed. Potential biases in self-reported data from participants.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Mahira S, Steven J, Cecile E, et al. Improving Glycaemic Outcomes with Flash Glucose Monitoring in Youth with Type 1 Diabetes in India. BMJ Paediatrics Open. 2026;10(1):e004606. doi:10.1136/bmjpo-2026-004606
Efectos Principales
FGM reduced HbA1c by -0.44% compared to SMBG (p=0.006).
In the FGM→SMBG group, HbA1c decreased from 8.6% to 7.9% at 3 months (p<0.05).
HbA1c remained unchanged at 9 and 12 months after crossover to SMBG.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Freestyle Libre 1 FGM use, Self-monitoring of blood glucose and HbA1c.
This study contributes evidence to
Primary intervention
Freestyle Libre 1 FGM use
Primary outcomes
- HbA1c
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
2
Evidence pairs
2
Relationships
1
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 55
1
Related topics
2
Evidence pairs
205
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 2 evidence relationships
- Includes primary outcome data
- Linked to 1 direct semantic evidence topic
Topic contributions
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
HbA1c Reduction
matched_outcome
Core evidence
Study findings
The primary outcomes reported in this study.
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 25
- Negative
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- FGM led to a significant HbA1c reduction of -0.44% (p=0.006).
- At 3 months, HbA1c decreased to 7.9% in the FGM group (p<0.05).
- No significant change in HbA1c after crossover to SMBG at 9 and 12 months.
A quién se aplica
- Youth aged 12-18 with Type 1 Diabetes.
- Participants residing in India.
Tener en Cuenta
- Results may not be applicable to adults or other populations.
- The study did not include long-term follow-up beyond 12 months.
- Differences in diabetes management practices across regions may affect outcomes.
Entre Líneas
- The study's sample size may limit generalizability.
- Long-term effects beyond 12 months were not assessed.
- Potential biases in self-reported data from participants.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Freestyle Libre 1 FGM use and HbA1c, Self-monitoring of blood glucose and HbA1c.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Devices & Technology
Freestyle Libre 1 FGM use → HbA1c
Devices & Technology
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceDevices & Technology
Self-monitoring of blood glucose → HbA1c
Devices & Technology
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 25
- Negative
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceIncluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
Freestyle Libre 1 FGM use Evidence Hub
All studies on Freestyle Libre 1 FGM use
1 studies
intervention_hubContributes to Freestyle Libre 1 FGM use evidence base.
HbA1c Evidence Hub
All studies measuring HbA1c
1 studies
outcome_hubMeasures HbA1c as a key outcome.
Self-monitoring of blood glucose Evidence Hub
All studies on Self-monitoring of blood glucose
1 studies
intervention_hubContributes to Self-monitoring of blood glucose evidence base.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Freestyle Libre 1 FGM use and HbA1c
Intervention: Freestyle Libre 1 FGM useOutcome: HbA1c
1 results
All studies on Self-monitoring of blood glucose and HbA1c
Intervention: Self-monitoring of blood glucoseOutcome: HbA1c
1 results
All studies on Freestyle Libre 1 FGM use
Intervention: Freestyle Libre 1 FGM use
1 results
All studies on Self-monitoring of blood glucose
Intervention: Self-monitoring of blood glucose
1 results
All studies measuring HbA1c
Outcome: HbA1c
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Freestyle Libre 1 FGM use improve HbA1c?
Emerging Evidence
Freestyle Libre 1 FGM use appears to improve HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Self-monitoring of blood glucose improve HbA1c?
Emerging Evidence
Self-monitoring of blood glucose may worsen HbA1c or be associated with harm.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
HRS-7535 improves glycemic control in adults with type 2 diabetesNewer diabetes drugs show stronger weight and blood sugar benefits in prediabetesGLP-1 agonists reduce heart fat thickness in diabetes.Metformin and glimepiride with basal insulin lowered HbA1c the mostNatural products may improve glycemic control in type 2 diabetes
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.